Predictive Oncology (POAI) Competitors $0.90 -0.01 (-0.82%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$0.91 +0.01 (+1.00%) As of 09/3/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock POAI vs. RBOT, MODD, NMTC, POCI, TMDIF, CLGN, VVOS, DRIO, RVP, and COCHShould you be buying Predictive Oncology stock or one of its competitors? The main competitors of Predictive Oncology include Vicarious Surgical (RBOT), Modular Medical (MODD), NeuroOne Medical Technologies (NMTC), Precision Optics (POCI), Titan Medical (TMDIF), CollPlant Biotechnologies (CLGN), Vivos Therapeutics (VVOS), DarioHealth (DRIO), Retractable Technologies (RVP), and Envoy Medical (COCH). These companies are all part of the "medical equipment" industry. Predictive Oncology vs. Its Competitors Vicarious Surgical Modular Medical NeuroOne Medical Technologies Precision Optics Titan Medical CollPlant Biotechnologies Vivos Therapeutics DarioHealth Retractable Technologies Envoy Medical Predictive Oncology (NASDAQ:POAI) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations. Does the media prefer POAI or RBOT? In the previous week, Vicarious Surgical had 1 more articles in the media than Predictive Oncology. MarketBeat recorded 2 mentions for Vicarious Surgical and 1 mentions for Predictive Oncology. Vicarious Surgical's average media sentiment score of 0.78 beat Predictive Oncology's score of -1.00 indicating that Vicarious Surgical is being referred to more favorably in the news media. Company Overall Sentiment Predictive Oncology Negative Vicarious Surgical Positive Which has preferable earnings and valuation, POAI or RBOT? Predictive Oncology has higher revenue and earnings than Vicarious Surgical. Vicarious Surgical is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPredictive Oncology$1.62M6.05-$12.66M-$3.05-0.30Vicarious SurgicalN/AN/A-$63.22M-$10.09-0.58 Do insiders & institutionals hold more shares of POAI or RBOT? 9.0% of Predictive Oncology shares are held by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are held by institutional investors. 3.4% of Predictive Oncology shares are held by company insiders. Comparatively, 12.0% of Vicarious Surgical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts prefer POAI or RBOT? Vicarious Surgical has a consensus target price of $7.00, suggesting a potential upside of 19.56%. Given Vicarious Surgical's higher probable upside, analysts clearly believe Vicarious Surgical is more favorable than Predictive Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Predictive Oncology 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Vicarious Surgical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is POAI or RBOT more profitable? Vicarious Surgical has a net margin of 0.00% compared to Predictive Oncology's net margin of -587.31%. Vicarious Surgical's return on equity of -148.14% beat Predictive Oncology's return on equity.Company Net Margins Return on Equity Return on Assets Predictive Oncology-587.31% -722.01% -167.23% Vicarious Surgical N/A -148.14%-98.07% Which has more risk & volatility, POAI or RBOT? Predictive Oncology has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. SummaryVicarious Surgical beats Predictive Oncology on 9 of the 13 factors compared between the two stocks. Get Predictive Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for POAI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding POAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POAI vs. The Competition Export to ExcelMetricPredictive OncologyMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.53M$2.05B$5.77B$9.76BDividend YieldN/AN/A6.66%4.49%P/E Ratio-0.3037.9782.3426.60Price / Sales6.059.48502.89158.84Price / CashN/A52.0425.7028.92Price / Book-6.006.5610.916.56Net Income-$12.66M-$63.67M$3.28B$266.04M7 Day Performance-1.64%-0.59%0.09%-0.89%1 Month Performance16.28%7.19%8.93%4.34%1 Year Performance-2.17%34.31%51.81%24.06% Predictive Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POAIPredictive Oncology0.205 of 5 stars$0.90-0.8%N/A-3.4%$9.53M$1.62M-0.3030Negative NewsShort Interest ↑RBOTVicarious Surgical1.3835 of 5 stars$6.76+0.3%$7.00+3.6%+4.0%$39.97MN/A-0.67210MODDModular Medical0.8425 of 5 stars$0.76+5.6%N/A-61.0%$39.80MN/A-1.4920NMTCNeuroOne Medical Technologies1.7063 of 5 stars$0.78-0.5%$1.45+85.8%-6.3%$39.23M$3.45M-5.2020Negative NewsShort Interest ↑Gap UpPOCIPrecision OpticsN/A$4.85-2.0%N/A-17.1%$37.95M$19.10M-5.4580Gap DownTMDIFTitan MedicalN/A$0.31-12.9%N/A+811.4%$35.66M$17.63M-0.2550Gap UpCLGNCollPlant Biotechnologies2.8847 of 5 stars$2.63+4.4%$11.50+337.3%-49.4%$32.04M$510K-2.3370Short Interest ↓Gap UpVVOSVivos Therapeutics0.2944 of 5 stars$4.63+10.2%$4.82+4.0%+73.9%$31.52M$14.39M-2.76160DRIODarioHealth1.9222 of 5 stars$0.55-3.5%$2.00+263.6%-43.3%$25.94M$27.04M-0.83200Stock SplitHigh Trading VolumeRVPRetractable Technologies2.6595 of 5 stars$0.85+1.8%N/A-14.7%$25.33M$38.16M-1.57240Positive NewsShort Interest ↓COCHEnvoy Medical2.4946 of 5 stars$1.12-2.6%$9.25+725.9%-60.1%$24.75M$220K-0.7834Analyst Revision Related Companies and Tools Related Companies Vicarious Surgical Competitors Modular Medical Competitors NeuroOne Medical Technologies Competitors Precision Optics Competitors Titan Medical Competitors CollPlant Biotechnologies Competitors Vivos Therapeutics Competitors DarioHealth Competitors Retractable Technologies Competitors Envoy Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:POAI) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
